The landscape of non-reference SINE-VNTR-Alus in amyotrophic lateral sclerosis

The fatal neurodegenerative disease, amyotrophic lateral sclerosis (ALS), leads to the degeneration of motor neurons in the brain and spinal cord. Many different genetic variants are known to increase the risk of developing ALS, however much of the disease heritability is still to be identified. To...

Full description

Saved in:
Bibliographic Details
Main Authors: Abigail L. Pfaff, Vivien J. Bubb, John P. Quinn, Sulev Kõks
Format: Article
Language:English
Published: Frontiers Media S.A. 2025-05-01
Series:Experimental Biology and Medicine
Subjects:
Online Access:https://www.ebm-journal.org/articles/10.3389/ebm.2025.10600/full
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849687485395763200
author Abigail L. Pfaff
Abigail L. Pfaff
Vivien J. Bubb
John P. Quinn
Sulev Kõks
Sulev Kõks
author_facet Abigail L. Pfaff
Abigail L. Pfaff
Vivien J. Bubb
John P. Quinn
Sulev Kõks
Sulev Kõks
author_sort Abigail L. Pfaff
collection DOAJ
description The fatal neurodegenerative disease, amyotrophic lateral sclerosis (ALS), leads to the degeneration of motor neurons in the brain and spinal cord. Many different genetic variants are known to increase the risk of developing ALS, however much of the disease heritability is still to be identified. To identify novel genetic factors, we characterised SINE-VNTR-Alu (SVA) presence/absence variation in 4403 genomes from the New York Genome Center (NYGC) ALS consortium. SVAs are a type of retrotransposon able to mobilise in the human genome generating new insertions that can modulate gene expression and mRNA splicing and to date 33 insertions are known to cause a range of genetic diseases. In the NYGC ALS consortium sequence data 2831 non-reference genome SVAs were identified and 95% of these insertions were rare with an insertion allele frequency of less than 0.01. Association analysis of the common SVAs with ALS risk, age at onset and survival did not identify any SVAs that survived correction for multiple testing. However, there were three different rare SVA insertions in the ALS associated gene NEK1 identified in four different individuals with ALS. The frequency of these rare insertions in NEK1 was significantly higher in the individuals with ALS from the NYGC ALS consortium compared to the gnomAD SV non-neuro controls (p = 0.0002). This study was the first to characterise non-reference SVA presence/absence variation in a large cohort of ALS individuals identifying insertions as potential candidates involved in disease development for further investigation.
format Article
id doaj-art-bb9cf94830194cf09b1b0587477acb8a
institution DOAJ
issn 1535-3699
language English
publishDate 2025-05-01
publisher Frontiers Media S.A.
record_format Article
series Experimental Biology and Medicine
spelling doaj-art-bb9cf94830194cf09b1b0587477acb8a2025-08-20T03:22:19ZengFrontiers Media S.A.Experimental Biology and Medicine1535-36992025-05-0125010.3389/ebm.2025.1060010600The landscape of non-reference SINE-VNTR-Alus in amyotrophic lateral sclerosisAbigail L. Pfaff0Abigail L. Pfaff1Vivien J. Bubb2John P. Quinn3Sulev Kõks4Sulev Kõks5Perron Institute for Neurological and Translational Science, Perth, WA, AustraliaPersonalised Medicine Centre, Health Futures Institute, Murdoch University, Perth, WA, AustraliaDepartment of Pharmacology and Therapeutics, Institute of Systems, Molecular and Integrative Biology, University of Liverpool, Liverpool, United KingdomDepartment of Pharmacology and Therapeutics, Institute of Systems, Molecular and Integrative Biology, University of Liverpool, Liverpool, United KingdomPerron Institute for Neurological and Translational Science, Perth, WA, AustraliaPersonalised Medicine Centre, Health Futures Institute, Murdoch University, Perth, WA, AustraliaThe fatal neurodegenerative disease, amyotrophic lateral sclerosis (ALS), leads to the degeneration of motor neurons in the brain and spinal cord. Many different genetic variants are known to increase the risk of developing ALS, however much of the disease heritability is still to be identified. To identify novel genetic factors, we characterised SINE-VNTR-Alu (SVA) presence/absence variation in 4403 genomes from the New York Genome Center (NYGC) ALS consortium. SVAs are a type of retrotransposon able to mobilise in the human genome generating new insertions that can modulate gene expression and mRNA splicing and to date 33 insertions are known to cause a range of genetic diseases. In the NYGC ALS consortium sequence data 2831 non-reference genome SVAs were identified and 95% of these insertions were rare with an insertion allele frequency of less than 0.01. Association analysis of the common SVAs with ALS risk, age at onset and survival did not identify any SVAs that survived correction for multiple testing. However, there were three different rare SVA insertions in the ALS associated gene NEK1 identified in four different individuals with ALS. The frequency of these rare insertions in NEK1 was significantly higher in the individuals with ALS from the NYGC ALS consortium compared to the gnomAD SV non-neuro controls (p = 0.0002). This study was the first to characterise non-reference SVA presence/absence variation in a large cohort of ALS individuals identifying insertions as potential candidates involved in disease development for further investigation.https://www.ebm-journal.org/articles/10.3389/ebm.2025.10600/fullretrotransposonsSVAamyotrophic lateral sclerosisneurodegenerationgenetics
spellingShingle Abigail L. Pfaff
Abigail L. Pfaff
Vivien J. Bubb
John P. Quinn
Sulev Kõks
Sulev Kõks
The landscape of non-reference SINE-VNTR-Alus in amyotrophic lateral sclerosis
Experimental Biology and Medicine
retrotransposons
SVA
amyotrophic lateral sclerosis
neurodegeneration
genetics
title The landscape of non-reference SINE-VNTR-Alus in amyotrophic lateral sclerosis
title_full The landscape of non-reference SINE-VNTR-Alus in amyotrophic lateral sclerosis
title_fullStr The landscape of non-reference SINE-VNTR-Alus in amyotrophic lateral sclerosis
title_full_unstemmed The landscape of non-reference SINE-VNTR-Alus in amyotrophic lateral sclerosis
title_short The landscape of non-reference SINE-VNTR-Alus in amyotrophic lateral sclerosis
title_sort landscape of non reference sine vntr alus in amyotrophic lateral sclerosis
topic retrotransposons
SVA
amyotrophic lateral sclerosis
neurodegeneration
genetics
url https://www.ebm-journal.org/articles/10.3389/ebm.2025.10600/full
work_keys_str_mv AT abigaillpfaff thelandscapeofnonreferencesinevntralusinamyotrophiclateralsclerosis
AT abigaillpfaff thelandscapeofnonreferencesinevntralusinamyotrophiclateralsclerosis
AT vivienjbubb thelandscapeofnonreferencesinevntralusinamyotrophiclateralsclerosis
AT johnpquinn thelandscapeofnonreferencesinevntralusinamyotrophiclateralsclerosis
AT sulevkoks thelandscapeofnonreferencesinevntralusinamyotrophiclateralsclerosis
AT sulevkoks thelandscapeofnonreferencesinevntralusinamyotrophiclateralsclerosis
AT abigaillpfaff landscapeofnonreferencesinevntralusinamyotrophiclateralsclerosis
AT abigaillpfaff landscapeofnonreferencesinevntralusinamyotrophiclateralsclerosis
AT vivienjbubb landscapeofnonreferencesinevntralusinamyotrophiclateralsclerosis
AT johnpquinn landscapeofnonreferencesinevntralusinamyotrophiclateralsclerosis
AT sulevkoks landscapeofnonreferencesinevntralusinamyotrophiclateralsclerosis
AT sulevkoks landscapeofnonreferencesinevntralusinamyotrophiclateralsclerosis